HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


U.S. Or China? Humane Cosmetics Act Could Force Multinationals To Choose

This article was originally published in The Rose Sheet

Executive Summary

The draft Humane Cosmetics Act differs in its wording from the European Cosmetics Regulation in a way that could address what animal-rights groups see as an unintended loophole in the EU's marketing ban – namely, its applicability to cosmetic animal testing under third-country regulations. The U.S. proposal ostensibly would bar products and ingredients from market if they've undergone cosmetic animal testing anywhere in the world, posing a potential dilemma for multinationals with business in China, for example.


Related Content

US Humane Cosmetics Act Expected Soon, House Reps Say
Multinational Ingredient Innovators Not Likely To Warm To Humane Cosmetics Act
Industry May Lean On Outside Animal Data If Humane Cosmetics Act Passes
Humane Cosmetics Act Lacks FDA Assurance Regarding Alternative Methods
Highest EU Court To Interpret Cosmetic Animal-Test Ban’s Scope
ECHA Clarifies Exceptions To Cosmetic Animal-Test Ban; NGOs Regroup



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts